Patanjali Group plans to float 4 IPOs in next five years.

Baba Ramdev's Patanjali Group plans for initial public offering ( IPO) of four of its companies namely, Patanjali Ayurved, Patanjali Medicine, Patanjali Wellness and Patanjali Lifestyle over the next five years.

The group has set an agenda of increasing its overall turnover to about Rs. 1 lakh crore in 5 to 7 years.

Baba Ramdev said, "We will launch at least four IPOs for sure - Patanjali Ayurved, Patanjali Medicine, Patanjali Wellness and Patanjali Lifestyle - in the next five years."

The yoga guru and businessman further added that Patanjali’s current revenue is Rs 40,000 crore.

Previously, in 2022 Patanjali Ayurved dispose its food retail business to group company Ruchi Soya Industries Ltd last month for Rs 690 crore. Through its follow-on public offer (FPO), Ruchi Soya collected Rs 4,300 crore, to clear its bank and long-term borrowings. 

Hereafter, the stake of the promoter was decreased to 80.82 percent, and the public shareholding stood at 19.18 percent.

According to the Securities and Exchange Board of India (SEBI) norms, the company needs to bring down the stake of promoter. This should be done in order to achieve the minimum public shareholding of 25 percent. Patanjali has around three years to strip stake of promoter to 75 percent.

It is to be noted that in 2020-21, Patanjali Ayurved had posted a turnover of Rs 9,783.81 crore, while other group entities such as Patanjali Natural Biscuits reported a turnover of Rs. 650 crore, its  ayurveda arm Divya Pharmacy Rs. 850 crore, and food processing arm Patanjali Agro Rs 1,600 crore.

Patanjali Foods CEO Sanjeev Asthana told the media recently that the company is not assured to have strategic investors. He further made clear that Patanjali Foods is the food Fast-moving consumer goods (FMCG) and Patanjali Ayurved is the non-food FMCG part of the business.

ALSO READ: Gautam Adani’s firm to supply power to Bangladesh from December